Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Cut to $115.00 by Analysts at Piper Sandler
Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) had its price objective decreased by Piper Sandler from...
Your Source for Insightful Trends and Discussions.
Ultragenyx Pharmaceutical (NASDAQ:RARE – Free Report) had its price objective decreased by Piper Sandler from...
Asana (NYSE:ASAN – Free Report) had its target price lowered by DA Davidson from $20.00...
Atria Investments Inc cut its stake in shares of TechnipFMC plc (NYSE:FTI – Free Report)...
StockNews.com lowered shares of TC Energy (NYSE:TRP – Free Report) (TSE:TRP) from a buy rating...
JPMorgan Chase & Co. downgraded shares of Campbell Soup (NASDAQ:CPB – Free Report) from an...
Marvell Technology (NASDAQ:MRVL – Get Free Report) had its price target lowered by equities researchers...
AutoZone, Inc. (NYSE:AZO – Free Report) – Analysts at William Blair decreased their FY2025 earnings...
New York State Common Retirement Fund trimmed its holdings in Maplebear Inc. (NASDAQ:CART – Free...
Royal Bank of Canada cut shares of Celanese (NYSE:CE – Free Report) from an outperform...
The Hain Celestial Group (NASDAQ:HAIN – Get Free Report) had its price objective dropped by...